The benefit of abciximab in percutaneous coronary revascularization is not device-specific. [electronic resource]
Producer: 20000712Description: 1060-4 p. digitalISSN:- 0002-9149
- Abciximab
- Angioplasty, Balloon, Coronary
- Antibodies, Monoclonal -- therapeutic use
- Atherectomy, Coronary
- Coronary Disease -- drug therapy
- Female
- Humans
- Immunoglobulin Fab Fragments -- therapeutic use
- Male
- Middle Aged
- Platelet Aggregation Inhibitors -- therapeutic use
- Proportional Hazards Models
- Randomized Controlled Trials as Topic
- Stents
- Survival Analysis
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.